These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20116902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C, Halder AK, Adhikari N, Jha T.
    Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH, Zihlif MA, Taha MO.
    Chem Biol Interact; 2016 Apr 25; 250():12-26. PubMed ID: 26954606
    [Abstract] [Full Text] [Related]

  • 27. Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors.
    Khanfar MA, Taha MO.
    J Mol Recognit; 2017 Sep 25; 30(9):. PubMed ID: 28299833
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling.
    Zalloum H, Tayyem R, Irmaileh BA, Bustanji Y, Zihlif M, Mohammad M, Rjai TA, Mubarak MS.
    J Mol Graph Model; 2015 Sep 25; 61():61-84. PubMed ID: 26188796
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation.
    Al-Sha'er MA, Mansi I, Khanfar M, Abudayyh A.
    J Enzyme Inhib Med Chem; 2016 Sep 25; 31(sup4):64-77. PubMed ID: 27569779
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A virtual screening study of the 18 kDa translocator protein using pharmacophore models combined with 3D-QSAR studies.
    Tuccinardi T, Taliani S, Bellandi M, Da Settimo F, Da Pozzo E, Martini C, Martinelli A.
    ChemMedChem; 2009 Oct 25; 4(10):1686-94. PubMed ID: 19688807
    [Abstract] [Full Text] [Related]

  • 36. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.
    Rano TA, Sieber-McMaster E, Pelton PD, Yang M, Demarest KT, Kuo GH.
    Bioorg Med Chem Lett; 2009 May 01; 19(9):2456-60. PubMed ID: 19339179
    [Abstract] [Full Text] [Related]

  • 37. Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.
    Shahin R, Alqtaishat S, Taha MO.
    J Comput Aided Mol Des; 2012 Feb 01; 26(2):249-66. PubMed ID: 22167443
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
    Lu XY, Chen YD, Jiang YJ, You QD.
    Eur J Med Chem; 2009 Sep 01; 44(9):3718-30. PubMed ID: 19428156
    [Abstract] [Full Text] [Related]

  • 40. Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors.
    AlQudah DA, Zihlif MA, Taha MO.
    Eur J Med Chem; 2016 Mar 03; 110():204-23. PubMed ID: 26840362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.